2026-2030年全球敗血症診斷市場

全球敗血症診斷市場預計將從 2025 年到 2030 年成長至 5.813 億美元，預測期內複合年成長率為 8.7%。

這份關於全球膿毒症診斷市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：敗血症和醫療相關感染負擔日益加重、快速分子診斷和生物標記技術的進步、即時檢測的普及以及人工智慧的融合應用。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、細分市場數據及區域分析，以及供應商格局數據。此外，報告還包含歷史數據和預測數據。

本研究指出，人工智慧和機器學習在診斷平台中的應用是未來幾年全球敗血症診斷市場成長的關鍵促進因素之一。此外，分散式即時檢測和微流體檢測的推廣、策略合作以及多項目症候群檢測的引入，預計也將顯著提升市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球敗血症診斷市場
• 2020-2024年基於技術的細分市場分析
• 按方法分類的細分市場分析，2020-2024 年
• 產品類型細分市場分析，2020-2024 年
• 按類型分類的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球膿毒症診斷市場
• 地緣政治衝突對全球膿毒症診斷市場的影響。

第7章：五力分析

第8章 市場區隔：依技術分類

• 比較：按技術
• 血液培養試驗
• 分子診斷
• 免疫測量
• 其他
• 市場機會：依技術分類

第9章 市場區隔：依方法

• 比較：依方法
• 傳統診斷方法
• 實驗室測試
• POCT
• 市場機會：依方法

第10章 市場區隔：依產品類型

• 比較：依產品類型
• 消耗品
• 裝置
• 市場機會：依產品類型分類

第11章 市場區隔：按類型

• 比較：按類型
• 細菌性敗血症
• 黴菌性敗血症
• 其他
• 市場機會：按類型分類

第12章 客戶狀況

第13章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第14章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第15章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第16章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Abionic SA
• BioMerieux SA
• Bruker Corp.
• DelphineDx
• DiaSorin SpA
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• QIAGEN NV
• Shenzhen Mindray Co. Ltd.
• Siemens Healthineers AG
• Snibe Co.Ltd.
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Waters Corp.

第17章附錄

The global sepsis diagnostics market is forecasted to grow by USD 581.3 mn during 2025-2030, accelerating at a CAGR of 8.7% during the forecast period. The report on the global sepsis diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing burden of sepsis and healthcare-associated infections, technological advancements in rapid molecular diagnostics and biomarkers, expansion of point-of-care testing and ai integration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global sepsis diagnostics market is segmented as below:

By Technology

• Blood culture tests
• Molecular diagnostics
• Immunoassays
• Others

By Method

• Conventional diagnostics
• Laboratory-based testing
• POCT

By Product Type

• Consumables
• Instruments

By Type

• Bacterial sepsis
• Fungal sepsis
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and ml in diagnostic platforms as one of the prime reasons driving the global sepsis diagnostics market growth during the next few years. Also, expansion of decentralized point-of-care testing and microfluidic assays and strategic collaborations and multiplex syndromic testing adoption will lead to sizable demand in the market.

The report on the global sepsis diagnostics market covers the following areas:

• Global sepsis diagnostics market sizing
• Global sepsis diagnostics market forecast
• Global sepsis diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global sepsis diagnostics market vendors that include Abbott Laboratories, Abionic SA, Beckman Coulter Inc., BioMerieux SA, Bruker Corp., Cepheid Inc., Cytovale Inc., Deepull Inc., DelphineDx, DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Immunexpress Pty. Ltd., MicroSensDx Ltd., QIAGEN N.V., Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Snibe Co.Ltd., Sysmex Corp., Thermo Fisher Scientific Inc., Waters Corp.. Also, the global sepsis diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Method
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Sepsis Diagnostics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Sepsis Diagnostics Market 2020 - 2024 ($ million)
• 5.2 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.3 Method segment analysis 2020 - 2024
  • Historic Market Size - Method Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global sepsis diagnostics market
• 6.2 Impact of geopolitical conflicts on global sepsis diagnostics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Technology

• 8.1 Market segments
• 8.2 Comparison by Technology
• 8.3 Blood culture tests - Market size and forecast 2025-2030
• 8.4 Molecular diagnostics - Market size and forecast 2025-2030
• 8.5 Immunoassays - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

9 Market Segmentation by Method

• 9.1 Market segments
• 9.2 Comparison by Method
• 9.3 Conventional diagnostics - Market size and forecast 2025-2030
• 9.4 Laboratory-based testing - Market size and forecast 2025-2030
• 9.5 POCT - Market size and forecast 2025-2030
• 9.6 Market opportunity by Method
  • Market opportunity by Method ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Consumables - Market size and forecast 2025-2030
• 10.4 Instruments - Market size and forecast 2025-2030
• 10.5 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Market Segmentation by Type

• 11.1 Market segments
• 11.2 Comparison by Type
• 11.3 Bacterial sepsis - Market size and forecast 2025-2030
• 11.4 Fungal sepsis - Market size and forecast 2025-2030
• 11.5 Others - Market size and forecast 2025-2030
• 11.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 Germany - Market size and forecast 2025-2030
  • 13.4.2 UK - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 China - Market size and forecast 2025-2030
  • 13.5.2 India - Market size and forecast 2025-2030
  • 13.5.3 Japan - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Indonesia - Market size and forecast 2025-2030
  • 13.5.6 Thailand - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 Brazil - Market size and forecast 2025-2030
  • 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Turkey - Market size and forecast 2025-2030
  • 13.6.5 Argentina - Market size and forecast 2025-2030
  • 13.6.6 Colombia - Market size and forecast 2025-2030
  • 13.6.7 South Africa - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Increasing burden of sepsis and healthcare-associated infections
  • Technological advancements in rapid molecular diagnostics and biomarkers
  • Expansion of point-of-care testing and AI integration
• 14.2 Market challenges
  • High cost of advanced diagnostic equipment and consumables
  • Unfavorable reimbursement policies and complex regulatory frameworks
  • Scarcity of skilled laboratory personnel and lack of awareness
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Integration of AI and ML in diagnostic platforms
  • Expansion of decentralized point-of-care testing and microfluidic assays
  • Strategic collaborations and multiplex syndromic testing adoption

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 16.5 Abionic SA
  • Abionic SA - Overview
  • Abionic SA - Product / Service
  • Abionic SA - Key offerings
  • SWOT
• 16.6 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 16.7 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 16.8 DelphineDx
  • DelphineDx - Overview
  • DelphineDx - Product / Service
  • DelphineDx - Key offerings
  • SWOT
• 16.9 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 16.10 EKF Diagnostics Holdings Plc
  • EKF Diagnostics Holdings Plc - Overview
  • EKF Diagnostics Holdings Plc - Business segments
  • EKF Diagnostics Holdings Plc - Key offerings
  • EKF Diagnostics Holdings Plc - Segment focus
  • SWOT
• 16.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 16.12 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 16.13 Shenzhen Mindray Co. Ltd.
  • Shenzhen Mindray Co. Ltd. - Overview
  • Shenzhen Mindray Co. Ltd. - Business segments
  • Shenzhen Mindray Co. Ltd. - Key offerings
  • Shenzhen Mindray Co. Ltd. - Segment focus
  • SWOT
• 16.14 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 16.15 Snibe Co.Ltd.
  • Snibe Co.Ltd. - Overview
  • Snibe Co.Ltd. - Product / Service
  • Snibe Co.Ltd. - Key offerings
  • SWOT
• 16.16 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 16.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 16.18 Waters Corp.
  • Waters Corp. - Overview
  • Waters Corp. - Business segments
  • Waters Corp. - Key offerings
  • Waters Corp. - Segment focus
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations